← Back to Clinical Trials
Recruiting NCT06934356

NCT06934356 Subcortical Arousal in Perceptual Awareness

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06934356
Status Recruiting
Phase
Sponsor Yale University
Condition Epilepsy
Study Type INTERVENTIONAL
Enrollment 72 participants
Start Date 2025-10-13
Primary Completion 2030-12

Trial Parameters

Condition Epilepsy
Sponsor Yale University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 72
Sex ALL
Min Age 13 Years
Max Age N/A
Start Date 2025-10-13
Completion 2030-12
Interventions
EEGEye TrackingBehavioral task

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The study is a multi-site study and will be conducted at up to 11 investigative sites in the United States. The study will investigate subcortical arousal circuits in visual perception using techniques with complementary strengths based on promising initial studies.

Eligibility Criteria

The following are the inclusion/exclusion criteria for epilepsy patients with thalamic electrodes age 13 years and up (Aim 1): Inclusion Criteria: * normal vision with or without the use of corrective lenses Exclusion Criteria: * severe vision impairment even with correction preventing ability to see stimuli (prevents accurate pupil and eye gaze measurements) * unable to perform the perception task due to cognitive impairment. All participants must be capable of consenting for themselves. The following are the inclusion/exclusion criteria for epilepsy patients with thalamic electrodes age 18 years and up (Aim 2): Inclusion Criteria: * normal vision with or without the use of corrective lenses * a female subject must have a negative pregnancy test and if sexually active, must be using a reliable form of birth control for the duration of the trial, be surgically sterile, or be at least two years post-menopausal. Exclusion Criteria: * severe vision impairment even with correction preventi

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology